Until recently, aging and ovariectomy (OVX) have been the primary rodent models available to examine effects of ovarian hormone loss. These models fail to adequately recapitulate the hormonal changes of the human menopause process. The intact aging model fails to achieve very low estrogen levels at post-menopause, and the OVX model lacks a peri-menopause phase. Conversely, the novel model of AOF successfully replicates the human peri- and post-menopause stages, including erratic estrous cycles and hormone fluctuations, followed by undetectable estrogen levels[1, 2]. In the AOF model, the ovotoxin 4-vinylcyclohexene diepoxide (VCD, Sigma-Aldrich) is injected (130 mg/kg in 0.5% dimethyl sulfoxide in sesame oil; 5 days/week for 3 weeks; i.p.) in mice which induces selective depletion of ovarian primary and primordial follicles[3]. Previous studies from the Milner lab and other groups confirmed that VCD administration does not negatively affect peripheral tissues nor crosses the blood-brain barrier [1, 2]. In addition to reducing confounds associated with surgical manipulations, the AOF model maintains the presence of ovarian tissue which importantly parallels to human menopause. Based on assessment of ovarian follicle depletion and responses of plasticity markers in brain areas known to be estrogen responsive, timepoints for pre-, peri- and post-AOF have been established [1-4].Timepoints in the AOF model include peri-AOF (>58 days) and post-AOF (>139 days) corresponding to human peri-and post-menopause respectively [1-5].
1.Van Kempen, T.A., et al., Characterization of neural estrogen signaling and neurotrophic changes in the accelerated ovarian failure mouse model of menopause. Endocrinology, 2014. 155(9): p. 3610-23.
2.Van Kempen, T.A., T.A. Milner, and E.M. Waters, Accelerated ovarian failure: a novel, chemically induced animal model of menopause.Brain Res, 2011. 1379: p. 176-87.
3.Lohff, J.C., et al., Effect of duration of dosing on onset of ovarian failure in a chemical-induced mouse model of perimenopause. Menopause, 2006. 13(3): p. 482-8.
4.Mayer, L.P., et al., The follicle-deplete mouse ovary produces androgen. Biol Reprod, 2004. 71(1): p. 130-8.
5.Marques-Lopes, J., et al., Redistribution of NMDA Receptors in Estrogen-Receptor-beta-Containing Paraventricular Hypothalamic Neurons following Slow-Pressor Angiotensin II Hypertension in Female Mice with Accelerated Ovarian Failure. Neuroendocrinology, 2017. 104(3): p. 239-256.